Literature DB >> 27747393

Exercise effects in Huntington disease.

Sebastian Frese1,2, Jens A Petersen1, Maria Ligon-Auer1, Sandro Manuel Mueller1,2, Violeta Mihaylova1, Saskia M Gehrig1,2, Veronika Kana3, Elisabeth J Rushing3, Evelyn Unterburger1, Georg Kägi4, Jean-Marc Burgunder5, Marco Toigo2,6, Hans H Jung7.   

Abstract

Huntington disease (HD) is a relentlessly progressive neurodegenerative disorder with symptoms across a wide range of neurological domains, including cognitive and motor dysfunction. There is still no causative treatment for HD but environmental factors such as passive lifestyle may modulate disease onset and progression. In humans, multidisciplinary rehabilitation has a positive impact on cognitive functions. However, a specific role for exercise as a component of an environmental enrichment effect has been difficult to demonstrate. We aimed at investigating whether endurance training (ET) stabilizes the progression of motor and cognitive dysfunction and ameliorates cardiovascular function in HD patients. Twelve male HD patients (mean ± SD, 54.8 ± 7.1 years) and twelve male controls (49.1 ± 6.8 years) completed 26 weeks of endurance training. Before and after the training intervention, clinical assessments, exercise physiological tests, and a body composition measurement were conducted and a muscle biopsy was taken from M. vastus lateralis. To examine the natural course of the disease, HD patients were additionally assessed 6 months prior to ET. During the ET period, there was a motor deficit stabilization as indicated by the Unified Huntington's Disease Rating Scale motor section score in HD patients (baseline: 18.6 ± 9.2, pre-training: 26.0 ± 13.7, post-training: 26.8 ± 16.4). Peak oxygen uptake ([Formula: see text]) significantly increased in HD patients (∆[Formula: see text] = +0.33 ± 0.28 l) and controls (∆[Formula: see text] = +0.29 ± 0.41 l). No adverse effects of the training intervention were reported. Our results confirm that HD patients are amenable to a specific exercise-induced therapeutic strategy indicated by an increased cardiovascular function and a stabilization of motor function.

Entities:  

Keywords:  Cardiovascular function; Endurance training; Motor function; Peak oxygen uptake (); Unified Huntington disease rating scale (UHDRS)

Mesh:

Year:  2016        PMID: 27747393     DOI: 10.1007/s00415-016-8310-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Aerobic high-intensity intervals improve VO2max more than moderate training.

Authors:  Jan Helgerud; Kjetill Høydal; Eivind Wang; Trine Karlsen; Pålr Berg; Marius Bjerkaas; Thomas Simonsen; Cecilies Helgesen; Ninal Hjorth; Ragnhild Bach; Jan Hoff
Journal:  Med Sci Sports Exerc       Date:  2007-04       Impact factor: 5.411

2.  Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.

Authors:  T Y C Pang; N C Stam; J Nithianantharajah; M L Howard; A J Hannan
Journal:  Neuroscience       Date:  2006-05-22       Impact factor: 3.590

3.  Physical therapy in Huntington's disease--toward objective assessments?

Authors:  S Bohlen; C Ekwall; K Hellström; H Vesterlin; M Björnefur; L Wiklund; R Reilmann
Journal:  Eur J Neurol       Date:  2012-06-04       Impact factor: 6.089

4.  A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease.

Authors:  Monica Busse; Lori Quinn; Katy Debono; Karen Jones; Johnathan Collett; Rebecca Playle; Mark Kelly; Sharon Simpson; Karianne Backx; David Wasley; Helen Dawes; Anne Rosser
Journal:  J Neurol Phys Ther       Date:  2013-12       Impact factor: 3.649

5.  Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle.

Authors:  Aaron P Russell; Jonas Feilchenfeldt; Sylvia Schreiber; Manu Praz; Antoinette Crettenand; Charles Gobelet; Christoph A Meier; David R Bell; Anastasia Kralli; Jean-Paul Giacobino; Olivier Dériaz
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

6.  Effects of aerobic exercise on mild cognitive impairment: a controlled trial.

Authors:  Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Brenna A Cholerton; Glen E Duncan; Pankaj D Mehta; Suzanne Craft
Journal:  Arch Neurol       Date:  2010-01

7.  Myopathy as a first symptom of Huntington's disease in a Marathon runner.

Authors:  Christoph M Kosinski; Christiane Schlangen; Frank N Gellerich; Zemfira Gizatullina; Markus Deschauer; Johannes Schiefer; Anne B Young; Georg Bernhard Landwehrmeyer; Klaus V Toyka; Bernd Sellhaus; Katrin S Lindenberg
Journal:  Mov Disord       Date:  2007-08-15       Impact factor: 10.338

8.  An assessment of verbal recall, recognition and fluency abilities in patients with Huntington's disease.

Authors:  N Butters; J Wolfe; E Granholm; M Martone
Journal:  Cortex       Date:  1986-03       Impact factor: 4.027

9.  Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model.

Authors:  David J Harrison; Monica Busse; Rebecca Openshaw; Anne E Rosser; Stephen B Dunnett; Simon P Brooks
Journal:  Exp Neurol       Date:  2013-07-30       Impact factor: 5.330

10.  Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease.

Authors:  Anton van Dellen; Patricia M Cordery; Tara L Spires; Colin Blakemore; Anthony J Hannan
Journal:  BMC Neurosci       Date:  2008-04-01       Impact factor: 3.288

View more
  19 in total

1.  Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.

Authors:  Jung-Hoon Koo; Joon-Yong Cho
Journal:  Neurotox Res       Date:  2017-06-27       Impact factor: 3.911

Review 2.  The protective role of exercise against age-related neurodegeneration.

Authors:  Alyson Sujkowski; Luke Hong; R J Wessells; Sokol V Todi
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

3.  Exercise Interventions in Huntington's Disease: An Individual Patient Data Meta-Analysis.

Authors:  Rebecca Playle; Polyxeni Dimitropoulou; Mark Kelson; Lori Quinn; Monica Busse
Journal:  Mov Disord Clin Pract       Date:  2019-07-18

4.  Alterations in the metabolic and cardiorespiratory response to exercise in Huntington's Disease.

Authors:  J J Steventon; J Collett; H Furby; K Hamana; C Foster; P O'Callaghan; A Dennis; R Armstrong; A H Németh; A E Rosser; K Murphy; L Quinn; M Busse; H Dawes
Journal:  Parkinsonism Relat Disord       Date:  2018-04-14       Impact factor: 4.402

5.  State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.

Authors:  Jessie S Gibson; Daniel O Claassen
Journal:  Expert Opin Pharmacother       Date:  2021-02-08       Impact factor: 4.103

6.  Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients.

Authors:  Sandro Manuel Mueller; Saskia Maria Gehrig; Jens A Petersen; Sebastian Frese; Violeta Mihaylova; Maria Ligon-Auer; Natalia Khmara; Jean-Marc Nuoffer; André Schaller; Carsten Lundby; Marco Toigo; Hans H Jung
Journal:  Orphanet J Rare Dis       Date:  2017-12-19       Impact factor: 4.123

7.  A genetic modifier suggests that endurance exercise exacerbates Huntington's disease.

Authors:  Silvia Corrochano; Gonzalo Blanco; Debbie Williams; Jessica Wettstein; Michelle Simon; Saumya Kumar; Lee Moir; Thomas Agnew; Michelle Stewart; Allison Landman; Vassilios N Kotiadis; Michael R Duchen; Henning Wackerhage; David C Rubinsztein; Steve D M Brown; Abraham Acevedo-Arozena
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

8.  Satellite cell content in Huntington's disease patients in response to endurance training.

Authors:  Sandro Manuel Mueller; Violeta Mihaylova; Sebastian Frese; Jens A Petersen; Maria Ligon-Auer; David Aguayo; Martin Flück; Hans H Jung; Marco Toigo
Journal:  Orphanet J Rare Dis       Date:  2019-06-11       Impact factor: 4.123

9.  Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease.

Authors:  Marie-France Paré; Bernard J Jasmin
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

10.  Skeletal Muscle Modulates Huntington's Disease Pathogenesis in Mice: Role of Physical Exercise.

Authors:  Silvia Corrochano; Gonzalo Blanco; Abraham Acevedo-Arozena
Journal:  J Exp Neurosci       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.